How can Alzheimer's disease blood-based biomarkers reach clinical practice?

Perneczky R, Quevenco FC, Hendrix J, Epelbaum S, Teunissen C, van der Flier WM, Suárez-Calvet M, Shi J, Mielke MM, Iwatsubo T, Palmqvist S, Hansson O

Open source

DOI
10.1002/dad2.70207
Published
2025 Oct-Dec
Container
Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70207,
  title = {How can Alzheimer's disease blood-based biomarkers reach clinical practice?},
  author = {Perneczky R and Quevenco FC and Hendrix J and Epelbaum S and Teunissen C and van der Flier WM and Suárez-Calvet M and Shi J and Mielke MM and Iwatsubo T and Palmqvist S and Hansson O},
  year = {2025},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.70207},
  url = {https://doi.org/10.1002/dad2.70207}
}

RIS

TY  - JOUR
TI  - How can Alzheimer's disease blood-based biomarkers reach clinical practice?
AU  - Perneczky R
AU  - Quevenco FC
AU  - Hendrix J
AU  - Epelbaum S
AU  - Teunissen C
AU  - van der Flier WM
AU  - Suárez-Calvet M
AU  - Shi J
AU  - Mielke MM
AU  - Iwatsubo T
AU  - Palmqvist S
AU  - Hansson O
PY  - 2025
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70207
UR  - https://doi.org/10.1002/dad2.70207
ER  - 

APA

R, P., FC, Q., J, H., S, E., C, T., WM, V. D. F., M, S., J, S., MM, M., T, I., S, P., & O, H. (2025). How can Alzheimer's disease blood-based biomarkers reach clinical practice?. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70207

Source records